v3.26.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]            
Revenue $ 2,121 $ 2,275 $ 4,469 $ 4,524 $ 9,972 $ 9,736
Cost of revenues 2,255 1,940 4,555 4,116 9,406 9,027
Gross profit (134) 335 (86) 408 566 709
Operating expenses:            
Research and development 728 664 1,419 1,219 2,526 2,713
General and administrative 2,316 1,569 4,759 2,596 5,971 6,162
Sales and marketing 749 839 4,041 1,115 1,321 1,417
Total operating expenses: 3,793 3,072 10,219 4,930 9,818 10,292
Loss from operations (3,927) (2,737) (10,305) (4,522) (9,252) (9,583)
Other income (expense), net:            
Financial expense, net (827) (369) (1,119) (746) (1,262) (1,340)
Other income 71   71    
Income before income taxes (4,754) (3,035) (11,424) (5,197) (10,514) (10,923)
Income tax expense 18 49 35 94
Net loss $ (4,772) $ (3,035) $ (11,473) $ (5,197) $ (10,549) $ (11,017)
Net loss per share - basic $ (4) $ (20.4) $ (11.4) $ (35) $ (44.61) $ (75)
Net loss per share - diluted $ (4) $ (20.4) $ (11.4) $ (35) $ (44.61) $ (75)
Weighted average number of common shares outstanding - basic 1,233 150 1,043 149 248 147
Weighted average number of common shares outstanding - diluted 1,233 150 1,043 149 248 147